News & Media – BioScience Managers

How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

News and Media

Saluda receives US FDA approval for automated programming platform in spinal cord stimulation

Announcement: Saluda Medical Announces Closing of $100 Million Financing

Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study

The Future of Medicine with Jeremy Curnock Cook and his vision for BioScience Managers

Critical to support innovation – We need to strike while the iron is hot, writes Jeremy Curnock Cook

Jeremy in Türkiye as a guest at the Foreign Economic Relations Board (DEIK)

Air supply: The ASX medtechs tackling respiratory illnesses

Canary Medical Scores Breakthrough Designation for Spine Implant

Saluda Medical Appoints Jim Erickson as Chief Financial Officer

Pages